Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994). «Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients». Lancet. 343 (8893): 311–22. doi:10.1016/s0140-6736(94)91161-4. PMID7905143.
Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. «Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial». Circulation. 112 (25): 3846–54. 2005. doi:10.1161/CIRCULATIONAHA.105.595397. PMID16291601.{{cite journal}}: CS1 սպաս․ այլ (link)
«Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro». Thromb Haemost. 62 (3): 923–6. 1989. doi:10.1055/s-0038-1651029. PMID2556812.
«Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction». Am J Cardiol. 61 (13): 971–4. 1988. doi:10.1016/0002-9149(88)90108-7. PMID2452564.
«Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis». JAMA. 283 (20): 2686–92. 2000. doi:10.1001/jama.283.20.2686. PMID10819952.
«Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials». Lancet. 361 (9351): 13–20. 2003. doi:10.1016/S0140-6736(03)12113-7. PMID12517460.
«A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group». N Engl J Med. 328 (10): 673–9. 1993. doi:10.1056/NEJM199303113281001. PMID8433725.
Boersma E, The Primary Coronary Angioplasty vs. Thrombolysis Group (2006). «Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients». Eur Heart J. 27 (7): 779–88. doi:10.1093/eurheartj/ehi810. PMID16513663.
«Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial». JAMA. 287 (15): 1943–51. 2002. doi:10.1001/jama.287.15.1943. PMID11960536.
«Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group». N Engl J Med. 341 (26): 1949–56. 1999. doi:10.1056/NEJM199912233412601. PMID10607811.
«Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators». Circulation. 98 (8): 734–41. 1998. doi:10.1161/01.cir.98.8.734. PMID9727542.
«Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial». Circulation. 108 (11): 1316–23. 2003. doi:10.1161/01.CIR.0000087601.45803.86. PMID12939213.
«Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock». JAMA. 294 (4): 448–54. 2005. doi:10.1001/jama.294.4.448. PMID16046651.
«In-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact». Acute Card Care. 10 (1): 15–25. 2008. doi:10.1080/17482940701474478. PMID17924228.
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994). «Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients». Lancet. 343 (8893): 311–22. doi:10.1016/s0140-6736(94)91161-4. PMID7905143.
Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators. «Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial». Circulation. 112 (25): 3846–54. 2005. doi:10.1161/CIRCULATIONAHA.105.595397. PMID16291601.{{cite journal}}: CS1 սպաս․ այլ (link)
«Effect of standard heparin and a low molecular weight heparin on thrombolytic and fibrinolytic activity of single-chain urokinase plasminogen activator in vitro». Thromb Haemost. 62 (3): 923–6. 1989. doi:10.1055/s-0038-1651029. PMID2556812.
«Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction». Am J Cardiol. 61 (13): 971–4. 1988. doi:10.1016/0002-9149(88)90108-7. PMID2452564.
«Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis». JAMA. 283 (20): 2686–92. 2000. doi:10.1001/jama.283.20.2686. PMID10819952.
«Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials». Lancet. 361 (9351): 13–20. 2003. doi:10.1016/S0140-6736(03)12113-7. PMID12517460.
«A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group». N Engl J Med. 328 (10): 673–9. 1993. doi:10.1056/NEJM199303113281001. PMID8433725.
Boersma E, The Primary Coronary Angioplasty vs. Thrombolysis Group (2006). «Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients». Eur Heart J. 27 (7): 779–88. doi:10.1093/eurheartj/ehi810. PMID16513663.
«Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial». JAMA. 287 (15): 1943–51. 2002. doi:10.1001/jama.287.15.1943. PMID11960536.
«Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group». N Engl J Med. 341 (26): 1949–56. 1999. doi:10.1056/NEJM199912233412601. PMID10607811.
«Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators». Circulation. 98 (8): 734–41. 1998. doi:10.1161/01.cir.98.8.734. PMID9727542.
«Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial». Circulation. 108 (11): 1316–23. 2003. doi:10.1161/01.CIR.0000087601.45803.86. PMID12939213.
«Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock». JAMA. 294 (4): 448–54. 2005. doi:10.1001/jama.294.4.448. PMID16046651.
«In-hospital arrhythmias in patients with acute myocardial infarction - the relation to the reperfusion strategy and their prognostic impact». Acute Card Care. 10 (1): 15–25. 2008. doi:10.1080/17482940701474478. PMID17924228.